A downtrend has been apparent in Schrodinger, Inc. (SDGR) lately. While the stock has lost 15.5% over the past week, it could ...

Schrodinger’s Cat is something that most of us are likely to have heard of at some point in our lives but how many of us actually know what it means? Well that is the subject of our little discussion ...

Schrodinger reported strong Q4 2023 results, but weak guidance for 2024, causing a significant drop in the share price. The demand environment continues to impact the software business, with growth ...

During the last three months, 4 analysts shared their evaluations of Schrodinger (NASDAQ:SDGR), revealing diverse outlooks from bullish to bearish. The following table encapsulates their recent ...

Schrodinger, Inc. (($SDGR)) has held its Q3 earnings call. Read on for the main highlights of the call. During Schrodinger, Inc.’s latest earnings ...

Schrodinger reported robust software and drug discovery revenue in the second quarter. Lilly's planned multi-billion-dollar acquisition of Morphic also provides another validation point for ...

A company that can speed up drug discovery; one that is already partnering with the world's 20 biggest drug companies and appears to be just scratching the surface of its potential. Sounds like a ...

Schrodinger (SDGR) today announced a research collaboration and license agreement with Novartis (NVS) to advance multiple development candidates into Novartis’s portfolio for further development. The ...

After a judge in Texas got the Food and Drug Administration’s approval of mifepristone, the drug used in medication abortions, suspended, access to the most commonly used method of abortion in the ...

Every few years a "Concept Company" files to list on the stock market, the latest being Tesla Inc (NASDAQ:TSLA) which disrupted and changed the transportation industry, according to Citron. There hasn ...